CN114470329A - Human albumin dermal filler - Google Patents
Human albumin dermal filler Download PDFInfo
- Publication number
- CN114470329A CN114470329A CN202210235705.6A CN202210235705A CN114470329A CN 114470329 A CN114470329 A CN 114470329A CN 202210235705 A CN202210235705 A CN 202210235705A CN 114470329 A CN114470329 A CN 114470329A
- Authority
- CN
- China
- Prior art keywords
- human albumin
- parts
- vitamin
- dermal filler
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention discloses a human albumin dermal filler, which comprises a human albumin raw material, normal saline, collagen, amino acid, hyaluronic acid, vitamin C and vitamin E; the beneficial effects of the invention are that collagen, amino acid, hyaluronic acid, vitamin C and vitamin E can improve the self-filling performance of the human albumin dermis and improve the using effect of the human albumin dermis filling.
Description
Technical Field
The invention relates to the field of human albumin application, in particular to a human albumin dermal filler.
Background
In the medical and American industry, when human albumin dermis is filled, reasonable treatment needs to be carried out on human albumin, normal saline is used in a traditional mode, but the functional effect is single, the perfect requirement on skin cannot be met, and the problem that the requirement effect of people on human albumin dermis filling is diversified cannot be met.
Disclosure of Invention
The present invention is designed to solve the above problems, and an object of the present invention is to provide a human albumin dermal filler.
The technical scheme of the invention is that the human albumin dermal filler comprises a human albumin raw material, normal saline, collagen, amino acid, hyaluronic acid, vitamin C and vitamin E.
The human albumin comprises 3-6 parts of raw materials, 2-10 parts of normal saline, 5-15 parts of collagen, 6-10 parts of amino acid, 1-3 parts of hyaluronic acid, 3-6 parts of vitamin C and 3-6 parts of vitamin E.
The human albumin comprises 4 parts of human albumin raw materials, 6 parts of physiological saline, 5 parts of collagen, 7 parts of amino acid, 2 parts of hyaluronic acid, 3 parts of vitamin C and 3 parts of vitamin E.
The human albumin raw material is taken, and then the physiological saline, the collagen, the amino acid, the hyaluronic acid, the vitamin C and the vitamin E are sequentially added and mixed.
The human albumin raw material is added with physiological saline to need low-temperature treatment.
The collagen, the amino acid, the hyaluronic acid, the vitamin C and the vitamin E are added, mixed and placed at low temperature for 3-6 hours.
When reagents are added, sterile operation is required.
The human albumin dermal filler prepared by the technical scheme of the invention comprises collagen, amino acid, hyaluronic acid, vitamin C and vitamin E, and can improve the self-filling performance of the human albumin dermal filler and improve the use effect of the human albumin dermal filler.
Detailed Description
The invention is described in detail below, a human albumin dermal filler, comprising human albumin raw material, normal saline, collagen, amino acid, hyaluronic acid, vitamin C and vitamin E;
the human albumin comprises 3-6 parts of raw materials, 2-10 parts of normal saline, 5-15 parts of collagen, 6-10 parts of amino acid, 1-3 parts of hyaluronic acid, 3-6 parts of vitamin C and 3-6 parts of vitamin E.
The human albumin comprises 4 parts of human albumin raw materials, 6 parts of physiological saline, 5 parts of collagen, 7 parts of amino acid, 2 parts of hyaluronic acid, 3 parts of vitamin C and 3 parts of vitamin E.
The human albumin raw material is taken, and then the physiological saline, the collagen, the amino acid, the hyaluronic acid, the vitamin C and the vitamin E are sequentially added and mixed.
The human albumin raw material is added with physiological saline to need low-temperature treatment.
The mixture added with collagen, amino acid, hyaluronic acid, vitamin C and vitamin E needs to be placed at low temperature for 3-6 hours.
When reagents are added, sterile handling is required.
The embodiment is characterized by comprising a human albumin raw material, normal saline, collagen, amino acid, hyaluronic acid, vitamin C and vitamin E, wherein the collagen, the amino acid, the hyaluronic acid, the vitamin C and the vitamin E can improve the dermal filling performance of the human albumin and improve the dermal filling using effect of the human albumin.
The technical solutions described above only represent the preferred technical solutions of the present invention, and some possible modifications to some parts of the technical solutions by those skilled in the art all represent the principles of the present invention, and fall within the protection scope of the present invention.
Claims (7)
1. The human albumin dermal filler is characterized by comprising a human albumin raw material, normal saline, collagen, amino acid, hyaluronic acid, vitamin C and vitamin E.
2. The human albumin dermal filler according to claim 1, wherein the human albumin raw material comprises 3-6 parts, 2-10 parts of normal saline, 5-15 parts of collagen, 6-10 parts of amino acid, 1-3 parts of hyaluronic acid, 3-6 parts of vitamin C and 3-6 parts of vitamin E.
3. The human albumin dermal filler according to claim 1, wherein the human albumin raw material comprises 4 parts, 6 parts of physiological saline, 5 parts of collagen, 7 parts of amino acid, 2 parts of hyaluronic acid, 3 parts of vitamin C, and 3 parts of vitamin E.
4. The human albumin dermal filler according to claim 2, wherein the human albumin raw material is prepared by sequentially adding physiological saline, collagen, amino acid, hyaluronic acid, vitamin C and vitamin E to the raw material, and mixing the mixture.
5. The human albumin dermal filler according to claim 1, wherein the human albumin raw material is added with physiological saline to be processed at a low temperature.
6. The human albumin dermal filler of claim 1, wherein the mixture of the collagen, the amino acid, the hyaluronic acid, the vitamin C and the vitamin E is allowed to stand at a low temperature for 3-6 hours.
7. The human albumin dermal filler of claim 1, wherein the addition of the agent requires sterile handling.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210235705.6A CN114470329A (en) | 2022-03-11 | 2022-03-11 | Human albumin dermal filler |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210235705.6A CN114470329A (en) | 2022-03-11 | 2022-03-11 | Human albumin dermal filler |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114470329A true CN114470329A (en) | 2022-05-13 |
Family
ID=81486837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210235705.6A Pending CN114470329A (en) | 2022-03-11 | 2022-03-11 | Human albumin dermal filler |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114470329A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100297182A1 (en) * | 2009-05-20 | 2010-11-25 | Tozzi Donna M | Injectable Amino-acid Composition |
| WO2013112488A2 (en) * | 2012-01-23 | 2013-08-01 | Kythera Biopharmaceuticals, Inc. | Dermal filling compositions and methods |
| CN109195579A (en) * | 2016-04-01 | 2019-01-11 | 韩国比奥科斯全球公司 | Include the cosmetic composition of albumin, hyaluronic acid or collagen as active constituent in cell culture medium |
| CN113368027A (en) * | 2018-09-30 | 2021-09-10 | 白晋 | Autologous collagen hydro-acupuncture and preparation method thereof |
| CN113663059A (en) * | 2021-08-31 | 2021-11-19 | 苏州姑苏欣颜魅丽医疗美容诊所有限公司 | Anti-aging beauty injection and preparation method thereof |
| CN113713180A (en) * | 2021-08-31 | 2021-11-30 | 尚诚怡美(成都)生物科技有限公司 | Cross-linked human albumin dermal filler and preparation method thereof |
-
2022
- 2022-03-11 CN CN202210235705.6A patent/CN114470329A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100297182A1 (en) * | 2009-05-20 | 2010-11-25 | Tozzi Donna M | Injectable Amino-acid Composition |
| WO2013112488A2 (en) * | 2012-01-23 | 2013-08-01 | Kythera Biopharmaceuticals, Inc. | Dermal filling compositions and methods |
| CN109195579A (en) * | 2016-04-01 | 2019-01-11 | 韩国比奥科斯全球公司 | Include the cosmetic composition of albumin, hyaluronic acid or collagen as active constituent in cell culture medium |
| CN113368027A (en) * | 2018-09-30 | 2021-09-10 | 白晋 | Autologous collagen hydro-acupuncture and preparation method thereof |
| CN113663059A (en) * | 2021-08-31 | 2021-11-19 | 苏州姑苏欣颜魅丽医疗美容诊所有限公司 | Anti-aging beauty injection and preparation method thereof |
| CN113713180A (en) * | 2021-08-31 | 2021-11-30 | 尚诚怡美(成都)生物科技有限公司 | Cross-linked human albumin dermal filler and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8142817B2 (en) | Composition for restoration of age related tissue loss in the face or selected areas of the body | |
| US8883131B2 (en) | Composition for the treatment of hair loss and baldness | |
| CN108210887A (en) | A kind of Medical cold application and preparation method thereof | |
| CN101791283B (en) | Cosmetic capable of eliminating striae gravidarum and scars | |
| CN108686255A (en) | It is a kind of to prevent the biological dressing and preparation method thereof that scar is formed | |
| CN105963771B (en) | A kind of medical dressing and preparation method thereof containing bioactive ingredients | |
| RU2383341C2 (en) | Method of skin rejuvenation | |
| CN108743921A (en) | It is a kind of to prevent the reparation liquid and its preparation method and application that scar is formed | |
| KR102452905B1 (en) | the method for skin improvement cosmetic composition containing natural spicule and polydioxanone and the cosmetic composition thereof | |
| CN113244160A (en) | Multi-effect skin care injection and preparation method thereof | |
| CN116509755B (en) | Inferior throwing separation type mask and mask essence containing same | |
| CN109010241A (en) | A kind of medicinal shin moisturizer and preparation method thereof for repairing skin keratin | |
| CN114470329A (en) | Human albumin dermal filler | |
| US20140348873A1 (en) | Urea-Silicone Gel for Hyperkeratosis Treatment | |
| CN112691076A (en) | Hypoallergenic soothing epidermal anesthesia cream and preparation method and application thereof | |
| CN111658573A (en) | Human-like serum protein preparation for regenerative medicine cosmetology | |
| KR20180134468A (en) | Cosmetic compositions comprising spicule, marine collagen and deep ocean water and their preparation | |
| CN104225577B (en) | A kind of double course for the treatment of compound cells growth factor hydrogels and preparation method and with application | |
| CN111012944A (en) | Liquid dressing based on alginate and hyaluronic acid and preparation method thereof | |
| CN110464832A (en) | A kind of polypeptide nursing bacteriostatic gel | |
| CN111743812A (en) | Vaginal repair nutrient solution and preparation method thereof | |
| CN100562306C (en) | Contain the biological beauty skin care item of body keratinized cell growth factor-2 and the preparation method of recombinant human keratinized cell growth factor-2 | |
| Wong et al. | Scar-free healing of wounds resulting commonly from domestic accidents | |
| CN106420399A (en) | Laser cosmetology nursing agent, preparation and use method thereof | |
| CN116350749B (en) | A pharmaceutical composition for treating diabetic foot and skin ulcer, and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220513 |